What is the management for a zolpidem (Ambien) overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Zolpidem (Ambien) Overdose

Immediate supportive care with gastric lavage, intravenous fluids, and respiratory monitoring is the mainstay of treatment for zolpidem overdose, with flumazenil as a potential reversal agent in severe cases. 1

Clinical Presentation

Zolpidem overdose typically presents with:

  • Impaired consciousness (ranging from somnolence to coma)
  • Respiratory depression
  • Cardiovascular compromise in severe cases
  • Pulmonary edema (may present with white foam in airway)

The severity of symptoms correlates with:

  • Dose ingested (severe symptoms more likely with doses >600mg)
  • Co-ingestion of other CNS depressants (particularly alcohol, benzodiazepines, or other psychotropic medications)

Management Algorithm

Step 1: Initial Assessment and Stabilization

  • Secure airway, breathing, and circulation
  • Obtain vital signs with continuous monitoring
  • Assess level of consciousness
  • Obtain IV access immediately

Step 2: Gastrointestinal Decontamination

  • Immediate gastric lavage if presentation is within 1-2 hours of ingestion 1
  • Activated charcoal may be considered if patient presents early and airway is protected

Step 3: Supportive Care

  • Administer intravenous fluids to maintain hemodynamic stability 1
  • Provide respiratory support as needed
  • Monitor for and treat hypotension
  • Withhold other sedating medications 1

Step 4: Pharmacological Intervention

  • For severe symptoms (coma, respiratory depression):

    • Consider flumazenil administration (though this may increase seizure risk) 1
    • Dosing: 0.2mg IV initially, may repeat up to 1mg total
  • For mild to moderate symptoms:

    • Supportive care is usually sufficient

Step 5: Monitoring and Disposition

  • Continuous cardiac monitoring for at least 24 hours
  • Frequent neurological assessments
  • ICU admission for:
    • Patients with respiratory compromise
    • Hemodynamic instability
    • Co-ingestion with other CNS depressants 2
    • Deep coma or absent brainstem reflexes 3

Special Considerations

Co-ingestions

Co-ingestion with other substances significantly increases morbidity:

  • Combined intoxications with other CNS-active drugs or alcohol can induce coma even at relatively low zolpidem doses (100-150mg) 4
  • Co-ingestion with over-the-counter medications (OR 3.33), other psychotropics (OR 3.11), or alcohol (OR 2.12) increases ICU admission rates 2

Prognosis

  • Single-drug zolpidem overdoses are generally benign with good outcomes 4, 5
  • Most patients recover rapidly with supportive care alone 5
  • Severe cases with respiratory failure or coma can still have complete neurological recovery with appropriate supportive management 3

Limitations of Treatment

  • Hemodialysis is not effective as zolpidem is not dialyzable 1
  • The value of activated charcoal is limited if presentation is delayed

Pitfalls to Avoid

  1. Underestimating co-ingestions: Always assume and evaluate for multiple drug ingestions, as these dramatically worsen outcomes
  2. Premature discharge: Monitor patients for at least 24 hours, especially with co-ingestions
  3. Overreliance on flumazenil: While effective, it may precipitate seizures in patients with benzodiazepine dependence or co-ingestion of pro-convulsant drugs
  4. Failure to consider zolpidem in comatose patients: Zolpidem overdose can cause deep coma with absent brainstem reflexes that can mimic brain death 3

In conclusion, while most single-drug zolpidem overdoses have favorable outcomes with supportive care, the presence of co-ingestions significantly increases morbidity and the need for intensive care. Prompt recognition and appropriate supportive management remain the cornerstones of treatment.

References

Research

[Acute overdose of Zolpidem (Stilnox)].

Schweizerische medizinische Wochenschrift, 1996

Research

Acute zolpidem poisoning--analysis of 344 cases.

Journal of toxicology. Clinical toxicology, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.